13

Abstract

Corinne Faivre-Finn MD PhD is an internationally recognised Consultant Clinical Oncologist and an Honorary Senior Lecturer in Manchester with an interest in lung cancer. Dr. Faivre-Finn trained in Paris until 1998 and took a consultant post in the UK, at the Christie Hospital in 2001. Her interests lie in the development of multimodality treatments for stage III non small-cell lung cancer and limited disease small-cell lung cancer. She is also interested in the development of stereotactic radiotherapy for early stage NSCLC and early phase trials combining thoracic radiotherapy and mechanism based therapies. She is an active member of the EORTC radiotherapy and lung groups and became the Radiotherapy Chair of the EORTC Lung Group in 2008. She is also the chair of the multimodality working group of the European Thoracic Oncology Platform (ETOP). She is involved with the trial management groups of several UK clinical trials in lung cancer and is the Chief Investigator of several trials including the international CONVERT study looking at the optimisation of concurrent chemo-radiation in limited disease small-cell lung cancer.